{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "a7de7e30",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "e34fad4a",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv('./../datasets/December_2021/reveal_story_dataset.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "e4db05fb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>NCTId</th>\n",
       "      <th>TrialAcronym</th>\n",
       "      <th>ArmGroupDescription</th>\n",
       "      <th>ArmGroupInterventionName</th>\n",
       "      <th>DrugsTested</th>\n",
       "      <th>OtherDrugNames</th>\n",
       "      <th>DrugMechanism</th>\n",
       "      <th>Sources</th>\n",
       "      <th>PreviouslyApproved</th>\n",
       "      <th>...</th>\n",
       "      <th>StatusVerifiedDate</th>\n",
       "      <th>StdAge</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StudyFirstPostDateType</th>\n",
       "      <th>StudyFirstSubmitDate</th>\n",
       "      <th>StudyFirstSubmitQCDate</th>\n",
       "      <th>StudyPopulation</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>VersionHolder</th>\n",
       "      <th>WhyStopped</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>284</td>\n",
       "      <td>NCT02008396</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Subjects will receive inactive placebo during ...</td>\n",
       "      <td>Drug: Placebo|Behavioral: Psychotherapy|Drug: ...</td>\n",
       "      <td>3,4-Methylenedioxymethamphetamine (MDMA)</td>\n",
       "      <td>Ecstasy</td>\n",
       "      <td>MDMA is a synthetic serotonergic agonist that ...</td>\n",
       "      <td>https://www.spectrumnews.org/news/ecstasy-ingr...</td>\n",
       "      <td>No</td>\n",
       "      <td>...</td>\n",
       "      <td>19-Jun</td>\n",
       "      <td>Adult|Older Adult</td>\n",
       "      <td>11-Dec-13</td>\n",
       "      <td>Estimate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6-Dec-13</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>15-Oct-21</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>176</td>\n",
       "      <td>NCT05030129</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ergoloid mesylates (EM) 1 mg three times daily...</td>\n",
       "      <td>Dietary Supplement: 5-Hydroxytryptophan / Vita...</td>\n",
       "      <td>5-Hydroxytryptophan|Vitamin B6|Ergoloid Mesylate</td>\n",
       "      <td>Oxitriptan|Pyridoxine|Dihydroergotoxine</td>\n",
       "      <td>5-Hydroxytryptophan is a compound that increas...</td>\n",
       "      <td>https://www.spectrumnews.org/opinion/genetic-r...</td>\n",
       "      <td>No|Yes|Yes</td>\n",
       "      <td>...</td>\n",
       "      <td>21-Aug</td>\n",
       "      <td>Adult</td>\n",
       "      <td>1-Sep-21</td>\n",
       "      <td>Actual</td>\n",
       "      <td>5-Aug-21</td>\n",
       "      <td>27-Aug-21</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>15-Oct-21</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>44</td>\n",
       "      <td>NCT04895215</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Drug: AB-2004|Drug: AB-2004|Drug: Placebo</td>\n",
       "      <td>AB-2004</td>\n",
       "      <td>None</td>\n",
       "      <td>AB-2004 is an experimental compound designed t...</td>\n",
       "      <td>https://www.nature.com/articles/d43747-020-011...</td>\n",
       "      <td>No</td>\n",
       "      <td>...</td>\n",
       "      <td>21-Oct</td>\n",
       "      <td>Child</td>\n",
       "      <td>20-May-21</td>\n",
       "      <td>Actual</td>\n",
       "      <td>17-May-21</td>\n",
       "      <td>17-May-21</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>9-Nov-21</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>17</td>\n",
       "      <td>NCT01300923</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The maximum dose of acamprosate to be used in ...</td>\n",
       "      <td>Drug: Acamprosate</td>\n",
       "      <td>Acamprosate</td>\n",
       "      <td>Campral</td>\n",
       "      <td>Acamprosate is a structural analogue of gamma-...</td>\n",
       "      <td>https://www.spectrumnews.org/news/finding-a-pa...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>...</td>\n",
       "      <td>19-Jul</td>\n",
       "      <td>Child</td>\n",
       "      <td>23-Feb-11</td>\n",
       "      <td>Estimate</td>\n",
       "      <td>25-Aug-10</td>\n",
       "      <td>18-Feb-11</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>15-Oct-21</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>204</td>\n",
       "      <td>NCT02998151</td>\n",
       "      <td>LAM</td>\n",
       "      <td>Placebo pill</td>\n",
       "      <td>Drug: Placebo|Drug: Acamprosate|Drug: Lovastat...</td>\n",
       "      <td>Acamprosate|Lovastatin|Minocycline</td>\n",
       "      <td>Campral|Altoprev,Mevacor|Cleeravue-M, Dynacin,...</td>\n",
       "      <td>Acamprosate is a structural analogue of gamma-...</td>\n",
       "      <td>https://www.spectrumnews.org/news/finding-a-pa...</td>\n",
       "      <td>Yes|Yes|Yes</td>\n",
       "      <td>...</td>\n",
       "      <td>20-Mar</td>\n",
       "      <td>Child|Adult</td>\n",
       "      <td>20-Dec-16</td>\n",
       "      <td>Estimate</td>\n",
       "      <td>1-Dec-16</td>\n",
       "      <td>15-Dec-16</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>15-Oct-21</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 147 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   index        NCTId TrialAcronym  \\\n",
       "0    284  NCT02008396          NaN   \n",
       "1    176  NCT05030129          NaN   \n",
       "2     44  NCT04895215          NaN   \n",
       "3     17  NCT01300923          NaN   \n",
       "4    204  NCT02998151          LAM   \n",
       "\n",
       "                                 ArmGroupDescription  \\\n",
       "0  Subjects will receive inactive placebo during ...   \n",
       "1  Ergoloid mesylates (EM) 1 mg three times daily...   \n",
       "2                                                NaN   \n",
       "3  The maximum dose of acamprosate to be used in ...   \n",
       "4                                       Placebo pill   \n",
       "\n",
       "                            ArmGroupInterventionName  \\\n",
       "0  Drug: Placebo|Behavioral: Psychotherapy|Drug: ...   \n",
       "1  Dietary Supplement: 5-Hydroxytryptophan / Vita...   \n",
       "2          Drug: AB-2004|Drug: AB-2004|Drug: Placebo   \n",
       "3                                  Drug: Acamprosate   \n",
       "4  Drug: Placebo|Drug: Acamprosate|Drug: Lovastat...   \n",
       "\n",
       "                                        DrugsTested  \\\n",
       "0          3,4-Methylenedioxymethamphetamine (MDMA)   \n",
       "1  5-Hydroxytryptophan|Vitamin B6|Ergoloid Mesylate   \n",
       "2                                           AB-2004   \n",
       "3                                       Acamprosate   \n",
       "4                Acamprosate|Lovastatin|Minocycline   \n",
       "\n",
       "                                      OtherDrugNames  \\\n",
       "0                                            Ecstasy   \n",
       "1            Oxitriptan|Pyridoxine|Dihydroergotoxine   \n",
       "2                                               None   \n",
       "3                                            Campral   \n",
       "4  Campral|Altoprev,Mevacor|Cleeravue-M, Dynacin,...   \n",
       "\n",
       "                                       DrugMechanism  \\\n",
       "0  MDMA is a synthetic serotonergic agonist that ...   \n",
       "1  5-Hydroxytryptophan is a compound that increas...   \n",
       "2  AB-2004 is an experimental compound designed t...   \n",
       "3  Acamprosate is a structural analogue of gamma-...   \n",
       "4  Acamprosate is a structural analogue of gamma-...   \n",
       "\n",
       "                                             Sources PreviouslyApproved  ...  \\\n",
       "0  https://www.spectrumnews.org/news/ecstasy-ingr...                 No  ...   \n",
       "1  https://www.spectrumnews.org/opinion/genetic-r...         No|Yes|Yes  ...   \n",
       "2  https://www.nature.com/articles/d43747-020-011...                 No  ...   \n",
       "3  https://www.spectrumnews.org/news/finding-a-pa...                Yes  ...   \n",
       "4  https://www.spectrumnews.org/news/finding-a-pa...        Yes|Yes|Yes  ...   \n",
       "\n",
       "  StatusVerifiedDate             StdAge StudyFirstPostDate  \\\n",
       "0             19-Jun  Adult|Older Adult          11-Dec-13   \n",
       "1             21-Aug              Adult           1-Sep-21   \n",
       "2             21-Oct              Child          20-May-21   \n",
       "3             19-Jul              Child          23-Feb-11   \n",
       "4             20-Mar        Child|Adult          20-Dec-16   \n",
       "\n",
       "  StudyFirstPostDateType StudyFirstSubmitDate StudyFirstSubmitQCDate  \\\n",
       "0               Estimate                  NaN               6-Dec-13   \n",
       "1                 Actual             5-Aug-21              27-Aug-21   \n",
       "2                 Actual            17-May-21              17-May-21   \n",
       "3               Estimate            25-Aug-10              18-Feb-11   \n",
       "4               Estimate             1-Dec-16              15-Dec-16   \n",
       "\n",
       "  StudyPopulation       StudyType VersionHolder WhyStopped  \n",
       "0             NaN  Interventional     15-Oct-21        NaN  \n",
       "1             NaN  Interventional     15-Oct-21        NaN  \n",
       "2             NaN  Interventional      9-Nov-21        NaN  \n",
       "3             NaN  Interventional     15-Oct-21        NaN  \n",
       "4             NaN  Interventional     15-Oct-21        NaN  \n",
       "\n",
       "[5 rows x 147 columns]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "f92c84ee",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>NCTId</th>\n",
       "      <th>TrialAcronym</th>\n",
       "      <th>ArmGroupDescription</th>\n",
       "      <th>ArmGroupInterventionName</th>\n",
       "      <th>DrugsTested</th>\n",
       "      <th>OtherDrugNames</th>\n",
       "      <th>DrugMechanism</th>\n",
       "      <th>Sources</th>\n",
       "      <th>PreviouslyApproved</th>\n",
       "      <th>...</th>\n",
       "      <th>StatusVerifiedDate</th>\n",
       "      <th>StdAge</th>\n",
       "      <th>StudyFirstPostDate</th>\n",
       "      <th>StudyFirstPostDateType</th>\n",
       "      <th>StudyFirstSubmitDate</th>\n",
       "      <th>StudyFirstSubmitQCDate</th>\n",
       "      <th>StudyPopulation</th>\n",
       "      <th>StudyType</th>\n",
       "      <th>VersionHolder</th>\n",
       "      <th>WhyStopped</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>314.000000</td>\n",
       "      <td>314</td>\n",
       "      <td>89</td>\n",
       "      <td>255</td>\n",
       "      <td>298</td>\n",
       "      <td>314</td>\n",
       "      <td>312</td>\n",
       "      <td>93</td>\n",
       "      <td>126</td>\n",
       "      <td>137</td>\n",
       "      <td>...</td>\n",
       "      <td>313</td>\n",
       "      <td>313</td>\n",
       "      <td>313</td>\n",
       "      <td>313</td>\n",
       "      <td>312</td>\n",
       "      <td>313</td>\n",
       "      <td>0.0</td>\n",
       "      <td>313</td>\n",
       "      <td>313</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>unique</th>\n",
       "      <td>NaN</td>\n",
       "      <td>314</td>\n",
       "      <td>84</td>\n",
       "      <td>250</td>\n",
       "      <td>261</td>\n",
       "      <td>134</td>\n",
       "      <td>118</td>\n",
       "      <td>19</td>\n",
       "      <td>23</td>\n",
       "      <td>5</td>\n",
       "      <td>...</td>\n",
       "      <td>119</td>\n",
       "      <td>5</td>\n",
       "      <td>289</td>\n",
       "      <td>2</td>\n",
       "      <td>282</td>\n",
       "      <td>289</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>top</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NCT02677051</td>\n",
       "      <td>CM-AT</td>\n",
       "      <td>ANAVEX2-73 liquid oral solution|Placebo liquid...</td>\n",
       "      <td>Drug: Aripiprazole</td>\n",
       "      <td>Oxytocin</td>\n",
       "      <td>None</td>\n",
       "      <td>This second-generation antipsychotic drug anta...</td>\n",
       "      <td>https://www.spectrumnews.org/opinion/how-to-im...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>...</td>\n",
       "      <td>21-Sep</td>\n",
       "      <td>Child</td>\n",
       "      <td>21-Sep-05</td>\n",
       "      <td>Estimate</td>\n",
       "      <td>13-Sep-05</td>\n",
       "      <td>13-Sep-05</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>15-Oct-21</td>\n",
       "      <td>Study terminated due to COVID-19 pandemic and ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>freq</th>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>6</td>\n",
       "      <td>22</td>\n",
       "      <td>25</td>\n",
       "      <td>16</td>\n",
       "      <td>19</td>\n",
       "      <td>102</td>\n",
       "      <td>...</td>\n",
       "      <td>20</td>\n",
       "      <td>175</td>\n",
       "      <td>4</td>\n",
       "      <td>220</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>313</td>\n",
       "      <td>303</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>161.302548</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>114.339697</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>79.500000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>158.500000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>235.750000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>1401.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>11 rows Ã— 147 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              index        NCTId TrialAcronym  \\\n",
       "count    314.000000          314           89   \n",
       "unique          NaN          314           84   \n",
       "top             NaN  NCT02677051        CM-AT   \n",
       "freq            NaN            1            2   \n",
       "mean     161.302548          NaN          NaN   \n",
       "std      114.339697          NaN          NaN   \n",
       "min        1.000000          NaN          NaN   \n",
       "25%       79.500000          NaN          NaN   \n",
       "50%      158.500000          NaN          NaN   \n",
       "75%      235.750000          NaN          NaN   \n",
       "max     1401.000000          NaN          NaN   \n",
       "\n",
       "                                      ArmGroupDescription  \\\n",
       "count                                                 255   \n",
       "unique                                                250   \n",
       "top     ANAVEX2-73 liquid oral solution|Placebo liquid...   \n",
       "freq                                                    2   \n",
       "mean                                                  NaN   \n",
       "std                                                   NaN   \n",
       "min                                                   NaN   \n",
       "25%                                                   NaN   \n",
       "50%                                                   NaN   \n",
       "75%                                                   NaN   \n",
       "max                                                   NaN   \n",
       "\n",
       "       ArmGroupInterventionName DrugsTested OtherDrugNames  \\\n",
       "count                       298         314            312   \n",
       "unique                      261         134            118   \n",
       "top          Drug: Aripiprazole    Oxytocin           None   \n",
       "freq                          6          22             25   \n",
       "mean                        NaN         NaN            NaN   \n",
       "std                         NaN         NaN            NaN   \n",
       "min                         NaN         NaN            NaN   \n",
       "25%                         NaN         NaN            NaN   \n",
       "50%                         NaN         NaN            NaN   \n",
       "75%                         NaN         NaN            NaN   \n",
       "max                         NaN         NaN            NaN   \n",
       "\n",
       "                                            DrugMechanism  \\\n",
       "count                                                  93   \n",
       "unique                                                 19   \n",
       "top     This second-generation antipsychotic drug anta...   \n",
       "freq                                                   16   \n",
       "mean                                                  NaN   \n",
       "std                                                   NaN   \n",
       "min                                                   NaN   \n",
       "25%                                                   NaN   \n",
       "50%                                                   NaN   \n",
       "75%                                                   NaN   \n",
       "max                                                   NaN   \n",
       "\n",
       "                                                  Sources PreviouslyApproved  \\\n",
       "count                                                 126                137   \n",
       "unique                                                 23                  5   \n",
       "top     https://www.spectrumnews.org/opinion/how-to-im...                Yes   \n",
       "freq                                                   19                102   \n",
       "mean                                                  NaN                NaN   \n",
       "std                                                   NaN                NaN   \n",
       "min                                                   NaN                NaN   \n",
       "25%                                                   NaN                NaN   \n",
       "50%                                                   NaN                NaN   \n",
       "75%                                                   NaN                NaN   \n",
       "max                                                   NaN                NaN   \n",
       "\n",
       "        ... StatusVerifiedDate StdAge StudyFirstPostDate  \\\n",
       "count   ...                313    313                313   \n",
       "unique  ...                119      5                289   \n",
       "top     ...             21-Sep  Child          21-Sep-05   \n",
       "freq    ...                 20    175                  4   \n",
       "mean    ...                NaN    NaN                NaN   \n",
       "std     ...                NaN    NaN                NaN   \n",
       "min     ...                NaN    NaN                NaN   \n",
       "25%     ...                NaN    NaN                NaN   \n",
       "50%     ...                NaN    NaN                NaN   \n",
       "75%     ...                NaN    NaN                NaN   \n",
       "max     ...                NaN    NaN                NaN   \n",
       "\n",
       "       StudyFirstPostDateType StudyFirstSubmitDate StudyFirstSubmitQCDate  \\\n",
       "count                     313                  312                    313   \n",
       "unique                      2                  282                    289   \n",
       "top                  Estimate            13-Sep-05              13-Sep-05   \n",
       "freq                      220                    5                      5   \n",
       "mean                      NaN                  NaN                    NaN   \n",
       "std                       NaN                  NaN                    NaN   \n",
       "min                       NaN                  NaN                    NaN   \n",
       "25%                       NaN                  NaN                    NaN   \n",
       "50%                       NaN                  NaN                    NaN   \n",
       "75%                       NaN                  NaN                    NaN   \n",
       "max                       NaN                  NaN                    NaN   \n",
       "\n",
       "       StudyPopulation       StudyType VersionHolder  \\\n",
       "count              0.0             313           313   \n",
       "unique             NaN               1             2   \n",
       "top                NaN  Interventional     15-Oct-21   \n",
       "freq               NaN             313           303   \n",
       "mean               NaN             NaN           NaN   \n",
       "std                NaN             NaN           NaN   \n",
       "min                NaN             NaN           NaN   \n",
       "25%                NaN             NaN           NaN   \n",
       "50%                NaN             NaN           NaN   \n",
       "75%                NaN             NaN           NaN   \n",
       "max                NaN             NaN           NaN   \n",
       "\n",
       "                                               WhyStopped  \n",
       "count                                                  33  \n",
       "unique                                                 33  \n",
       "top     Study terminated due to COVID-19 pandemic and ...  \n",
       "freq                                                    1  \n",
       "mean                                                  NaN  \n",
       "std                                                   NaN  \n",
       "min                                                   NaN  \n",
       "25%                                                   NaN  \n",
       "50%                                                   NaN  \n",
       "75%                                                   NaN  \n",
       "max                                                   NaN  \n",
       "\n",
       "[11 rows x 147 columns]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.describe(include = 'all')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8917736c",
   "metadata": {},
   "source": [
    "### Questions to Answer"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "077f6111",
   "metadata": {},
   "source": [
    "1) How many trials were terminated, and for what reasons?\n",
    "\n",
    "2) What is the most common drug tested, and the second, and the third most common?\n",
    "\n",
    "3) How many studies have actually posted results?\n",
    "\n",
    "4) What fraction of studies that have been completed have posted results?\n",
    "\n",
    "5) What are the most common conditions, and in what fractions?\n",
    "\n",
    "6) What fraction of drugs in clinical trials have been approved for another condition?\n",
    "\n",
    "7) What are the commonly occuring 'combined modality' types? Comment specifically on those trials.\n",
    "\n",
    "8) What is the earliest trial? The latest trial?\n",
    "\n",
    "9) Put together descriptive statistics on the 'Lead Author Country'.\n",
    "\n",
    "10) Who sponsors most studies? Industry or academia?\n",
    "\n",
    "11) What are the ranges of minimum and maximum ages?"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cfc402b4-76fa-403b-a736-610344547aae",
   "metadata": {},
   "source": [
    "## #1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "2874503a-bd1f-49fe-8f96-c0c429819ad4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "314"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "b3d6b7e8",
   "metadata": {},
   "outputs": [],
   "source": [
    "stopped_trials = df['WhyStopped'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "eac94cfc-a8ae-4fbb-9460-0db6092fcd20",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "33"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(stopped_trials)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "4817e1d8-3e38-4f45-9573-dd04d8c3bd44",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.10509554140127389"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "33/314"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "5a8ba4df-066f-4116-8ab3-04e68274c72f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study terminated due to COVID-19 pandemic and recruitment challenges in parent study                                                                               1\n",
       "Failure to recruit                                                                                                                                                 1\n",
       "too few subjects enrolled                                                                                                                                          1\n",
       "the recently feasibility study shows that the number of patients is insufficient in the centers                                                                    1\n",
       "This study was halted prior to enrolling.                                                                                                                          1\n",
       "Study treatment AFQ056 failed to demonstrate efficacy in the adult patient with Fragile X Syndrome in 2 other clinical studies (CAFQ056B2214 and CAFQ056A2212)     1\n",
       "Study terminated due to enrollment challenges during COVID-19 pandemic.                                                                                            1\n",
       "Well tolerated but failed to demonstrate significant activity. So it did not meet its primary endpoint or key secondary endpoints.                                 1\n",
       "Temporarily stopped due to COVID-19 pandemic.                                                                                                                      1\n",
       "Non-compliance                                                                                                                                                     1\n",
       "Withdrawn for problem of logistics with the associated laboratories                                                                                                1\n",
       "No eligible patients were enrolled                                                                                                                                 1\n",
       "Most of our patients had no willingness to participate in the survey                                                                                               1\n",
       "This study was withdrawn due to competing research interests and slow recruitment.                                                                                 1\n",
       "The study did not demonstrate evidence of efficacy on the primary or secondary efficacy variables                                                                  1\n",
       "Due to a change in the research priorities of the principal investigator in combination with low subject interest.                                                 1\n",
       "Study was not initiated it was decided to cancel this study                                                                                                        1\n",
       "all active subjects were rolled into study 209AS209/NCT01706523                                                                                                    1\n",
       "Low recruitment                                                                                                                                                    1\n",
       "The study treatment failed to demonstrate efficacy in target population in two other clinical studies (CAFQ056B2214 and CAFQ056A2212).                             1\n",
       "pending further evaluation                                                                                                                                         1\n",
       "lack of funding                                                                                                                                                    1\n",
       "Pharmaceutical and financial difficulties                                                                                                                          1\n",
       "The 24-week analysis indicated no clinical or statistical benefit for the primary endpoint for the overall study population. No new safety concerns identified.    1\n",
       "Was not possible to enroll sufficient number of subjects to draw any worthwhile conclusions from the study.                                                        1\n",
       "all active subjects rolled into 209FX303/NCT01013480                                                                                                               1\n",
       "Unsuccessful in recruiting appropriate subjects.                                                                                                                   1\n",
       "A futility analysis assessed that the study is highly unlikely to meet the pre-defined primary objective of the study. No new safety concerns were identified.     1\n",
       "Study changed to a placebo controlled trial of dextromethorphan                                                                                                    1\n",
       "The study was terminated due to enrollment challenges and the COVID-19 pandemic.                                                                                   1\n",
       "The study stopped recruitment of new participants due to COVID. A substudy was developed with adaptations to the main design.                                      1\n",
       "Terminated because primary efficacy parameter failed to demonstrate statistically significant difference between memantine and placebo in controlled trials        1\n",
       "Study not started                                                                                                                                                  1\n",
       "Name: WhyStopped, dtype: int64"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stopped_trials"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "eed2c2f6-2f04-4830-93d6-2dea763712d6",
   "metadata": {},
   "source": [
    "## #2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "61934419-421d-45dd-add0-b7e8d85e7fac",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Oxytocin                            22\n",
       "Aripiprazole                        16\n",
       "Cannabidiol                         14\n",
       "Risperidone                         11\n",
       "Everolimus                          11\n",
       "                                    ..\n",
       "Vitamin D|Vitamin E                  1\n",
       "Ketamine|Dexmedetomidine             1\n",
       "Recombinant human growth hormone     1\n",
       "Rett-T                               1\n",
       "Amitriptyline                        1\n",
       "Name: DrugsTested, Length: 134, dtype: int64"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "druglist = df['DrugsTested'].value_counts()\n",
    "druglist"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1828b207-641c-4c81-a7a1-b0a8c7f4f711",
   "metadata": {},
   "source": [
    "Oxytocin is the most frequently tested drug, with 22 trials. Aripiprazole has 16 trials, and cannabidiol is in third with 14 trials. Fascinating!"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "841c85d2-258d-4a59-891f-bd73ae88048a",
   "metadata": {},
   "source": [
    "## #3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "787f92b1-d95f-4845-86b6-24b1864d7017",
   "metadata": {},
   "outputs": [],
   "source": [
    "postedresults = df['ResultsFirstPostDateType'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "59fee243-eee3-436b-b9bb-b8697df9fd48",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Actual                     63\n",
       "Estimate                   47\n",
       "U.S. FDA Grant/Contract     1\n",
       "Name: ResultsFirstPostDateType, dtype: int64"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "postedresults"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "4d1e08de-a850-4ab5-aaf1-a9f532fa31c5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.20063694267515925"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "63 / len(df)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1a0162d3-5b13-444d-acd9-49df58a330d3",
   "metadata": {},
   "source": [
    "## #4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "d291d066-3f51-4eb5-a5e0-ebaa278af389",
   "metadata": {},
   "outputs": [],
   "source": [
    "conditions = df['Condition'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "f914e9ac-8cc3-448b-ab31-c33cae66b54b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Autism                                         185\n",
       "Fragile X syndrome                              39\n",
       "Tuberous sclerosis complex                      27\n",
       "Rett syndrome                                   24\n",
       "Angelman syndrome                                6\n",
       "Antipsychotic-usage weight gain                  6\n",
       "Phelan-McDermid syndrome                         5\n",
       "Tuberous sclerosis complex-related tumors        4\n",
       "Autism with ADHD                                 4\n",
       "Tuberous sclerosis complex-related seizures      3\n",
       "Autism-related irritability                      3\n",
       "Williams syndrome                                2\n",
       "ADHD with autism                                 2\n",
       "Autism-related sleep disorder                    1\n",
       "Velocardiofacial syndrome                        1\n",
       "15q duplication syndrome                         1\n",
       "Autism-related anxiety                           1\n",
       "Name: Condition, dtype: int64"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "conditions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "d0b2658d-611a-4d70-be1d-0bff0a4706de",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.08598726114649681"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "27/len(df)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2362292c-3967-45f9-a867-d3ca422e4e85",
   "metadata": {},
   "source": [
    "## Lead Sponsor analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "0a34c658-1777-4937-ac32-4c5f87d43059",
   "metadata": {},
   "outputs": [],
   "source": [
    "leadsponsors = df['LeadSponsorClass'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "6d9085e0-a467-4f7d-9092-04bfd4bf89df",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Academia                         183\n",
       "Industry                         104\n",
       "Other                             13\n",
       "National Institutes of Health      9\n",
       "Individual                         3\n",
       "Government                         2\n",
       "Name: LeadSponsorClass, dtype: int64"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "leadsponsors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "ca1d0ffd-c915-4502-9b52-281a2b7bec35",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.5828025477707006"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "183 / len(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "895ac5b1-2ff5-464a-8a4b-eb322edd73e0",
   "metadata": {},
   "outputs": [],
   "source": [
    "countries = df['LeadSponsorCountry'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "bcaa0bcd-ecdf-44ec-ab9d-2017ad60af51",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "United States     207\n",
       "Canada             18\n",
       "Switzerland        16\n",
       "United Kingdom     12\n",
       "Japan              12\n",
       "France             12\n",
       "Israel              8\n",
       "Australia           5\n",
       "China               4\n",
       "Spain               4\n",
       "Egypt               3\n",
       "Belgium             3\n",
       "Italy               1\n",
       "South Korea         1\n",
       "Brazil              1\n",
       "New Zealand         1\n",
       "Poland              1\n",
       "Netherlands         1\n",
       "Taiwan              1\n",
       "Pakistan            1\n",
       "Name: LeadSponsorCountry, dtype: int64"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "countries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f238463d-65b7-4959-878a-48cc578ad213",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
